Evidence map›Paper›PMID 34483909›Full record

ArticleFrontiers in pharmacology2021

Collagen Mimetic Peptides Promote Corneal Epithelial Cell Regeneration.

Robert O Baratta, Brian J Del Buono, Eric Schlumpf, Brian P Ceresa, David J Calkins

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Around the collagen triple helix: an introduction to studying associated genetic and acquired diseases.Matrix biology : journal of the International Society for Matrix Biology · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Robert O BarattaStuart Therapeutics, Stuart, FL, United States.
Brian J Del BuonoStuart Therapeutics, Stuart, FL, United States.
Eric SchlumpfStuart Therapeutics, Stuart, FL, United States.
Brian P CeresaDepartment of Ophthalmology and Visual Sciences, University of Louisville School of Medicine, Louisville, KY, United States.
David J CalkinsDepartment of Ophthalmology and Visual Sciences, Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, TN, United States.
Advanced Technologies Group (United States) · USUniversity of Louisville · USVanderbilt University Medical Center · US

Funding

Chemical Optimization of c-Cbl Antagonists for Corneal Wound HealingR01EY028911 · NEI · UNIVERSITY OF LOUISVILLE · PI CERESA, BRIAN P. · 2019 to 2023
$1.9M
NEI NIH HHS R01 EY028911
6 · The paper itself

Abstract

The cornea of the eye is at risk for injury through constant exposure to the extraocular environment. A highly collagenous structure, the cornea contains several different types distributed across multiple layers. The anterior-most layer contains non-keratinized epithelial cells that serve as a barrier to environmental, microbial, and other insults. Renewal and migration of basal epithelial cells from the limbus involve critical interactions between secreted basement membranes, composed primarily of type IV collagen, and underlying Bowman's and stromal layers, which contain primarily type I collagen. This process is challenged in many diseases and conditions that insult the ocular surface and damage underlying collagen. We investigated the capacity of a collagen mimetic peptide (CMP), representing a fraction of a single strand of the damaged triple helix human type I collagen, to promote epithelial healing following an acute corneal wound.

Indexed as

anti-inflammationcollagen mimetic peptidescollagen molecular activitycollagen reparativecorneal collagen damageocular surface diseaseregeneration

Identifiers

PMID34483909
PMCPMC8415399
OpenAlexW3195119448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.